Q97912220

Summary

Q97912220 is a committee group motion^[1].

Key Facts

• Q97912220 authored Kenneth Johansson^[2].
• Q97912220 authored Annika Qarlsson^[3].
• Q97912220 authored Lars-Ivar Ericson^[4].
• Q97912220 authored Birgitta Carlsson^[5].
• Q97912220 authored Birgitta Sellén^[6].
• Q97912220 authored Sofia Larsen^[7].
• Q97912220's instance of is recorded as committee group motion^[8].
• Q97912220's part of the series is recorded as motions of the 2004-2005 legislative session of the Riksdag^[9].
• Q97912220's language of work or name is recorded as Swedish^[10].
• Q97912220 was released on +2005-03-03T00:00:00Z^[11].
• Q97912220's main subject is medication^[12].
• Q97912220's work available at URL is recorded as http://data.riksdagen.se/dokument/GS02So9^[13].
• Q97912220's work available at URL is recorded as http://data.riksdagen.se/dokumentstatus/GS02So9^[14].
• Q97912220's applies to jurisdiction is recorded as Sweden^[15].
• Q97912220's legal citation of this text is recorded as Mot. 2004/05:So9^[16].
• Q97912220's title is recorded as med anledning av prop. 2004/05:70 Ökad patientsäkerhet på läkemedelsområdet^[17].
• Q97912220's has immediate cause is recorded as Q98138519^[18].
• Q97912220's cites work is recorded as Q98138519^[19].
• Q97912220's maintained by WikiProject is recorded as Project Riksdagen's documents^[20].
• Q97912220's copyright status is recorded as public domain^[21].
• Q97912220's legislative committee is recorded as Committee on Health and Welfare^[22].

Body

Definition and Type

Q97912220's instance of is recorded as committee group motion^[8].